| To: Moonray who wrote (209198) | 7/23/2020 2:07:46 PM | | From: oldbeachlvr | | | | Apple -4% on facing consumer protection probe - Axios
Multiple states are investigating Apple (NASDAQ: AAPL) for deceiving customers, according to the Tech Transparency Project via Axios.
A document obtained through a public records request says the Texas AG's Consumer Protection Division launched the investigation "for enforcement purposes."
Key quote: "If violations are uncovered, CPD will initiate enforcement proceedings. Accordingly, the OAG anticipates litigation in this matter."
It isn't clear what specific practices are targeted in the investigations.
Apple is currently facing antitrust investigations from U.S. House lawmakers and the European Union.
Apple shares are down 3.9% to $373.91.
Earlier today, Goldman told investors to avoid Apple shares, noting a price tag of $299.
From Seeking Alpha seekingalpha.com |
| | Apple Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (2) |
|
| To: OrionX who wrote (209200) | 7/23/2020 2:46:45 PM | | From: Moonray | | | | Goldman capitalizing on perceived bad news? In a way.
Keeping a sell but raising target to $299 from $263
on a stock pushing $400 is just CYA so that people
can't see HOW WRONG he really was/is. If AAPL
sells off to $320, he can say "Look how close to my
$299 target AAPL has come".
o~~~ O |
| | Apple Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Moonray | 7/23/2020 3:30:06 PM | | | | | | With a decline of 5% today, what do my charts say about where AAPL is going?
Looks like a decline to $330 on the first chart.
I would be surprised if the P&F low is their $345. Looks like $330 to me.
o~~~ O |
| | Apple Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Moonray | 7/23/2020 3:58:58 PM | | | | | | Abbott receives FDA approval for Patient Controller app
Abbott (ABT) announced it has received approval from the
U.S. FDA for the use of the company's Patient Controller
app on compatible personal Apple (AAPL) smartphone
devices.
At Abbott, this approval allows patients living with neurological
conditions, including chronic pain or movement disorders, the
ability to manage therapy directly from their personal smartphone.
With this app approval, the need to carry a separate patient
programmer device is eliminated, streamlining the patient's
experience and seamlessly integrating therapy management
into their life.
This is an important step in the integration and connection
of digital health tools that ultimately help patients live fuller,
healthier lives.
o~~~ O |
| | Apple Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Zen Dollar Round | 7/23/2020 5:44:55 PM | | | | | | Rumor, rumor, rumor
Apple to push back iPhone 12 event to late October: report
Fans of iPhone will probably have to wait at least another month before shiny new models are unveiled. Apple Inc. AAPL is delaying its annual fall event until the latter half of October instead of early September, according to a tech blog. The company was forced to push back the event for the 5G-compatible iPhone 12 line because of production delays caused by the pandemic, the Japanese Apple blog Mac Otakara reported. Apple is expected to announce four new iPhones, with the 5G models available in November. Apple shares are up 26.5% this year. The broader S&P 500 index SPX is up 0.2% in 2020.
Link: marketwatch.com |
| | Apple Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (1) |
|
| |
